Bart Friedman - 11 Jun 2021 Form 4 Insider Report for Ovid Therapeutics Inc. (OVID)

Role
Director
Signature
/s/ Danielle Mann for Bart Friedman by PoA
Issuer symbol
OVID
Transactions as of
11 Jun 2021
Net transactions value
$0
Form type
4
Filing time
11 Jun 2021, 20:22:36 UTC
Previous filing
18 May 2021
Next filing
04 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OVID Stock Option (Right to Buy) Award $0 +15,000 $0.000000 15,000 11 Jun 2021 Common Stock 15,000 $4.49 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest in full on June 11, 2022 subject to the Reporting Person's continuous service through such vesting date.